Thanks to Congress's Incompetence, Milk Prices Are About to

New Post Public Reply Private Reply Replies (1) Message Board
fitzkarz

Thanks to Congress's Incompetence, Milk Prices Are About to Double

By Jordan Weissmann

Share 4 Dec 28 2012, 3:27 PM ET 32

This is dumb. Astonishingly, breathtakingly dumb.

Thanks to Congress's failure to pass a new version of the farm bill, the last edition of which officially expired on September 30, American consumers are about to see the price of milk at the grocery store to skyrocket in the new year. It might even  double to around $6 or $7 a gallon. That is, unless our elected officials defy their recent track record and manage to legislate a fix before January 1.

The media has predictably dubbed this debacle "the dairy cliff." It's cheeky. It's even sort of apt, in that it evokes a mindless herd of cattle falling into a canyon somewhere. How better to describe our politics at this point? But jokey nickname aside, this is a fairly serious situation. The price of milk, after all, isn't just the price of milk. It influences the cost of every dairy product made in the United States -- whether it's the cheese that Dominoes throws on its pizza, the butter used in bakeries, or, yes, the cartons milk public schools buy for lunch trays.

So how'd we get here? Ordinarily, Congress passes the farm bill, which governs everything from nutrition programs like food stamps, to disaster assistance for farmers, to agricultural subsidies, on a temporary, five-year basis. If it expires, as it did this year, we eventually revert back to the law as it existed in 1949, which was the last time a permanent farm bill was passed. And therein lies the problem.

Federal law puts a giant safety net under the dairy industry by promising that if the price of milk collapses, the government will swoop in and push it back up by buying mass quantities of dairy products. The goal is to make sure that the farmers are paid somewhere close to what it should cost them to produce the milk, a figure that's determined by a complex formula. Usually, dairies can earn plenty selling their product on the open market, and the government doesn't need to intervene. But the 1949 law getting ready to kick back in bases its formula for the cost of milk production on how the industry worked in the early 20th century, when it was far, far, far less efficient than today. As a result, it will automatically force the government to start paying a giant premium for milk products, which will then cause prices to jump for everyone else as well.

To give you a sense of how farcical this situation is, it's not even clear that the government has enough storage space to stow away all the dry milk, cheese blocks, and butter tubs it will have to purchase for absolutely no reason.

This is obviously not something that any rational person wants, including farmers, who prefer not to have the profitable private market ravaged by a pointless Washington intervention. "It's really serious," Dana Brooks, a lobbyist at the National Milk Producers Federation, told me. "We've never had this, and never would have dreamed we would be in this position."

Washington Post Columnist Charles Krauthammer has suggested that going over the "dairy cliff" might have an upside, in that it would force Americans to recognize that we have "insane laws, that acquire barnacles over decades." The problem is that the law, in this case, isn't insane -- our politics are. There was a time when the unacceptable threat of allowing essential legislation contained within the farm bill to expire would have prodded Congress to make compromises and strike a deal on its more controversial elements. That was the same thinking behind the fiscal cliff. But we may be reaching the point in our politics where that assumption no longer holds.

And so now we're about to see the very dumb results.

I'm in it to win it!

NASDAQ DIP and RIP
Here is the best word that describes what i do here.
Intuitive;
means having the ability to understand or know something without any direct evidence or reasoning process.

I was born with it, I'm truly blessed!


Alway's searching for winners'
937206596_images.jpg
Scroll down for more posts ▼

Top 10 Most Recent News Articles

OUTFRONT Media Gears Up for Q3 2026 Earnings Reveal

Updated Category News Views 3

OUTFRONT Media’s Earnings Drumroll Heading toward that red-letter date of November 5, OUTFRONT Media (NYSE: OUT) has got its ducks in a row. They're ready to spill the beans on third-quarter numbers after close of market—just as clocks hit 4:30 p.m. Eastern. It’s showtime, folks. What’s at Stake? We're talking OUTFRONT Media—one of the big kahunas in out-of-home...

Continue Reading
WF Holding Cancels Additional Purchase Rights in Deal

Updated Category News Views 4

WF Holding Calls Off Extra Purchase Rights Well, someone's decided to hit the brakes over at WF Holding Limited (NASDAQ:WFF). They're pulling the plug on an extra purchase gravy train they’d previously left open for investors. Straight from Kuala Lumpur, WF Holding's been in the fiberglass plastic game for over three decades, pushing out a product line that's almost as...

Continue Reading
Pediatric Dental Visits: Setting the Stage Early Matters

Updated Category News Views 4

Unlocking the Secrets of First Dental Visits When should little ones start showing up in that dental chair? You might be thinking, "I'll wait until they actually have a full set of chompers," but that's a rookie move, folks. A piece coming out of HelloNation suggests parents hustle those kiddos into the dentist's office by their first birthday or six months after the...

Continue Reading
Savarese Joins RID to Drive Diagnostic Innovation

Updated Category News Views 3

A Seasoned Leader Bolsters RID's Ambitions Mario Savarese has joined Rapid Infection Diagnostics Inc.'s Strategic Advisory Board, and let me tell ya, this move's got potential. Appointing a heavyweight like Savarese as an advisor isn’t just a nod to his hefty resume. It’s about vaulting a burgeoning company into the big leagues. He's got over 20 years steering a ship...

Continue Reading
Guwahati Training Elevates Ophthalmologists: More Ready Surgeons

Updated Category News Views 4

Expanding Horizons: Training Where It's Needed The universe of cataract surgery in India saw an encouraging turn with HelpMeSee's recent initiative in Guwahati. This operation hit the sweet spot for Northeast India's ophthalmologists by bringing top-notch surgical training directly to their doorstep. Bye-bye long, costly trips to distant cities for training—this time,...

Continue Reading
3D Concrete Printing Set to Transform Construction by 2035

Updated Category News Views 3

Concrete Revolution: The 3D Printing Surge Times are changing in construction, and this ain’t your grandfather’s cinder block. We're talking about 3D concrete printing here—an industry poised to swell from just a pipedream sort of $293.4 million in 2025 to a staggering $1.87 billion by 2035. Driven by housing demands and resilient defense contracts, the sector is...

Continue Reading
Direct Digital's Bold Exit: Delists from Nasdaq

Updated Category News Views 3

Delisting Drama: Navigating Direct Digital's Market Move Looks like Direct Digital Holdings is getting caught up in the whirlwind of delisting and deregistering its Class A common stock from the Nasdaq. This move isn't just about hopping off a big exchange—it’s a whole new set of dance steps in the market. Timing and Mechanics of the Departure They’ve set their...

Continue Reading
Cognizant Buys DyFlex for SAP, AI Edge in ANZ

Updated Category News Views 0

Why Cognizant's Move Matters Imagine being at the top of your game, only to realize you need more heavy-hitters to keep your edge. That’s this deal in a nutshell. Cognizant (NASDAQ: CTSH) is diving deep into AI-led enterprise transformation by scooping up DyFlex Solutions, a name with plenty of clout in the SAP ecosystem. What's Behind the DyFlex Acquisition? Founded in...

Continue Reading
FFR Set to Unveil Strategy at Nasdaq Event in NYC

Updated Category News Views 12

An Exciting Day for FFR on Wall Street Hold onto your hats, investors! FF EAI Robotics Ecosystem Inc. (NASDAQ: FFR) is about to make a splash in the big leagues at its much-anticipated Nasdaq listing ceremony. Slated for October 26 at the iconic Nasdaq Tower in NYC, it's a day that could pivot the company’s future centerpiece strategy, jacking up anticipation like...

Continue Reading
Factors Driving Up Car Window Tinting Costs Explained

Updated Category News Views 2

Decoding the Dollars Behind Car Window Tinting When you think about car upgrades, window tinting might not scream excitement. But, my friends, it ain't all about the aesthetics. Dive into the nuts and bolts of cost with insights from Francis Alegre, a seasoned pro from StayShine Detailing in Voorhees, New Jersey, featured in HelloNation's rundown. The Glass Mass Factor...

Continue Reading

Top 5 Most Recently Viewed Articles

Definitive Healthcare Celebrated as a Top Boston Employer

Updated Category News Views 89

Definitive Healthcare Honored as a Premier Workplace Definitive Healthcare (NASDAQ: DH), a leading name in healthcare commercial intelligence, has recently earned prestigious recognition as one of the top employers in Boston. Celebrated by Built In’s 2025 Best Places to Work program, this accolade acknowledges businesses that foster exceptional workplace environments....

Continue Reading
Euroseas Q4 Earnings Beat Expectations: Key Insights

Updated Category News Views 157

Euroseas Earnings Report: Highlights and Performance The market loves a good surprise, and Euroseas just tossed a nice one into the mix with their latest earnings. Released February 25, 2026, at 08:00 AM, they’ve performed better than expected, snagging attention from investors ready for a ride. Earnings Overview Let’s cut to the chase: Euroseas reported an earnings...

Continue Reading
AstraZeneca and Daiichi Sankyo's Datroway: A Game Changer

Updated Category News Views 208

Introduction to Datroway's Impact on Breast Cancer Treatment AstraZeneca Plc (NASDAQ: AZN) and Daiichi Sankyo have announced remarkable findings from their TROPION-Breast02 Phase 3 trial for the drug Datroway (datopotamab deruxtecan), set to revolutionize the approach to treating triple-negative breast cancer (TNBC). This pharmaceutical collaboration showcases significant...

Continue Reading
Compute Exchange Revolutionizes AI Compute Market Dynamics

Updated Category News Views 806

Compute Exchange Revolutionizes AI Compute Market Dynamics Today marks a significant shift in the way AI compute resources are bought and sold with the introduction of Compute Exchange. This pioneering platform provides the first open exchange specifically designed for GPUs and various other compute resources, addressing the needs of both buyers and sellers in an...

Continue Reading
NuZee Stock Surges on Major Operational Changes and Leadership Shift

Updated Category News Views 88

NuZee Inc. Makes Headlines with Strategic Relocation NuZee, Inc. NUZE is witnessing a significant surge in its stock trading activity. The reason behind this movement is the recent announcement of the company relocating its U.S. operations from California to Florida. This strategic decision aims to bolster its operational efficiency and accessibility. Global Expansion...

Continue Reading